Back to top
more

Dentsply Sirona (XRAY)

(Real Time Quote from BATS)

$10.81 USD

10.81
1,473,740

-0.08 (-0.74%)

Updated Aug 25, 2026 02:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

New Strong Sell Stocks for Nov. 11

by Zacks Equity Research

XRAY, EDNMY and SLVM have been added to the Zacks Rank #5 (Strong Sell) List on Nov.11, 2025

Zacks Equity Research

Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects

by Zacks Equity Research

Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Indrajit Bandyopadhyay headshot

XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View

by Indrajit Bandyopadhyay

DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.

Zacks Equity Research

Compared to Estimates, Dentsply (XRAY) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Dentsply International (XRAY) Lags Q3 Earnings Estimates

by Zacks Equity Research

Dentsply (XRAY) delivered earnings and revenue surprises of -17.78% and +0.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock?

by Zacks Equity Research

Dentsply Sirona's Q3 results may reveal ongoing softness in U.S. demand and orthodontic segments despite steady cost control.

Zacks Equity Research

Earnings Preview: Dentsply International (XRAY) Q3 Earnings Expected to Decline

by Zacks Equity Research

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Dentsply Sirona Retains Wellspect Following Strategic Review

by Zacks Equity Research

XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.

Zacks Equity Research

Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand

by Zacks Equity Research

COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.

Zacks Equity Research

Is the Options Market Predicting a Spike in DENTSPLY Stock?

by Zacks Equity Research

Investors need to pay close attention to XRAY stock based on the movements in the options market lately.